Across TCGA pan-cancer cohorts, TOMM70 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TOMM70 data layer compared with 20 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TOMM70 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TOMM70 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC and LUSC are the cancer types where TOMM70 Mutation most reproducibly stratifies survival.